CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 14.56
-0.24 (-1.62%)
Jul 9, 2026, 4:08 PM HKT
HKG:2171 Market Cap
HKG:2171 has a market cap or net worth of 8.66 billion as of July 9, 2026. Its market cap has decreased by -36.02% in one year.
Market Cap
8.66B
Enterprise Value
7.47B
Revenue
139.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.56
Market Cap Chart
Since June 18, 2021, HKG:2171's market cap has decreased from 17.02B to 8.66B, a decrease of -49.13%. That is a compound annual growth rate of -12.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 8.66B | 4.91% |
| Dec 31, 2025 | 8.25B | 63.11% |
| Dec 31, 2024 | 5.06B | 35.24% |
| Dec 29, 2023 | 3.74B | -56.36% |
| Dec 30, 2022 | 8.57B | -45.06% |
| Dec 31, 2021 | 15.61B | -8.30% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TenNor Therapeutics (Suzhou) | 10.17B |
| HBM Holdings | 10.13B |
| Nanjing Leads Biolabs | 9.92B |
| Everest Medicines | 9.62B |
| Suzhou Ribo Life Science | 8.84B |
| CStone Pharmaceuticals | 8.55B |
| Abbisko Cayman | 8.30B |
| LongBio Pharma (Suzhou) | 8.02B |